July 23, 2010 / 12:09 PM / 7 years ago

UPDATE 1-NxStage Q2 loss narrows, ups 2010 revenue view

* Q2 loss/shr $0.17 vs est loss/shr $0.18

* Revenue rises 21 pct to $44 mln

* Ups 2010 revenue to $170-$175 mln vs est $168.6 mln

July 23 (Reuters) - Dialysis products maker NxStage Medical Inc (NXTM.O) posted a narrower-than-expected quarterly loss, helped by strong performance across its segments, and raised its full-year revenue view.

The company now expects 2010 revenue of $170 million to $175 million but maintained its loss outlook of 60 cents to 71 cents a share for the year.

Analysts on average were expecting a loss of 65 cents a share, on revenue of $168.6 million, according to Thomson Reuters I/B/E/S.

For the second quarter, the company reported a net loss of $8.3 million, or 17 cents a share, compared with a loss of $12.5 million, or 27 cents a share, a year ago.

Revenue rose 21 percent to $44 million. Its home market grew 37 percent while its in-center market grew 4 percent and critical care segment rose 27 percent.

Analysts on average were expecting a loss of 18 cents a share, on revenue of $41.1 million.

Shares of the company closed at $13.88 Thursday on Nasdaq. (Reporting by Anand Basu in Bangalore; Editing by Gopakumar Warrier)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below